Clinical trial
Comparison of Regional Citrate Anticoagulation (RCA) and Regional Anticoagulation by Citrate-Free Decalcification in Renal (RACD) Replacement Therapy Using Sustained Low-Efficiency Dialysis
NCT04968587 is registered in ClinicalTrials.gov with Groupe Hospitalier Sud Ile-de-France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Regional Citrate Anticoagulation (RCA) and Regional Anticoagulation by Citrate-Free Decalcification in Renal (RACD) Replacement Therapy Using Sustained Low-Efficiency Dialysis
- Lead sponsor
- Groupe Hospitalier Sud Ile-de-France
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- February 1, 2022
- Completion date
- November 1, 2025
- Enrollment
- 138 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.